RSS feed (help)
Annual Review
- Annual Review 2007 (32 pages, 2762 KB) 21 Nov 2007
- Annual Review 2007 - Part 1 (11 pages, 476 KB) 21 Nov 2007
- Annual Review 2007 - Part 2 (6 pages, 933 KB) 21 Nov 2007
- Annual Review 2007 - Part 3 (5 pages, 1092 KB) 21 Nov 2007
- Annual Review 2007 - Part 4 (10 pages, 531 KB) 21 Nov 2007
- PHARMAC Annual Review 2006 (32 pages, 7116 KB) 24 Nov 2006
- PHARMAC Annual Review 2005 (28 pages, 6467 KB) 10 Nov 2005
- PHARMAC Annual Review 2004 (28 pages, 1445 KB) 28 Oct 2004
- PHARMAC Annual Review 2003 (32 pages, 887 KB) 11 Nov 2003
- PHARMAC Annual Review 2002 (28 pages, 1059 KB) 04 Nov 2002
- PHARMAC Annual Review 2001 (31 pages, 944 KB) 01 Oct 2001
- Annual Review - year ended 30 June 2000 (31 pages, 1176 KB) 17 Oct 2000
- Annual Review - year ended 30 June 1999 (31 pages, 746 KB) 14 Dec 1999
- Annual Review - year ended 30 June 1997 (26 pages, 987 KB) 02 Oct 1998
- Annual Review - year ended 30 June 1998 (29 pages, 1209 KB) 02 Oct 1998
Page updated on 13 Feb 2008
Linked documents
Annual Review 2007 - Part 3 (5 pages, 1092 KB)
18 HIV/AIDS Improving New Zealanders’ access to HIV treatments was a major theme in 2006-07. Five new treatments were added to the Pharmaceutical Schedule, including the first of a new type of HIV medicine, a fusion inhibitor. The five new…
PHARMAC Annual Review 2006 (32 pages, 7116 KB)
PHARMAC invested in health by providing new or expanded access to 41 subsidised treatments New investments include treatments for cardiovascular risk, schizophrenia, rheumatoid arthritis, osteoporosis, hepatitis, Parkinson’s disease, multiple…
PHARMAC Annual Review 2002 (28 pages, 1059 KB)
Major PHARMAC achievements in 2001-02 were: Providing new or wider access to 24 subsidised treatments, including those for raised cholesterol, multiple sclerosis, schizophrenia, epilepsy, arthritis and hay fever under cost-neutral and/or financially sustainable arrangements. Containing pharmaceutical expenditure growth by successfully negotiating savings worth approximately $36.8 million...
Annual Review - year ended 30 June 1999 (31 pages, 746 KB)
R Annual evıew for the year ended 30 June 1999 P H A R M AC (the Pharmaceutical Management Agency Ltd) is a not-for-profit company owned by the Health Funding Authority (HFA). Its role is to manage the national Pharmaceutical…
